Bruton's tyrosine-kinase-deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4

Scandinavian Journal of Immunology

Volumn 49, Issue 2, 1999, Pages 155-161

  Forssell, J ^b   Nilsson, A ^b   Sideras, P ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CD86 ANTIGEN; CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYCLINE; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PHORBOL DIBUTYRATE; PROTEIN P27; PROTEIN TYROSINE KINASE; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEFICIENCY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; B-LYMPHOCYTES; CELL CYCLE PROTEINS; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DOWN-REGULATION; G1 PHASE; IMMUNOGLOBULIN M; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICROTUBULE-ASSOCIATED PROTEINS; PHORBOL ESTERS; PROTEIN-TYROSINE KINASES; PROTEINS; S PHASE; TUMOR SUPPRESSOR PROTEINS;

EID: 0001766539     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00483.x     Document Type: Article

References (39)

1. Vetrie D, Vorechovsky I, Sideras P et al. The gene involved in X-linked agammaglobulinemia is a member of the src family of protein tyrosine kinases. Nature 1993;361:226-33.
2. Tsukada S, Saffran DC, Rawlings DJ et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993;72:279-90.
3. Thomas JD, Sideras P, Smith CIA, Vorechovsky I, Chapman PV, Paul WE. Colocalisation of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 1993;261:355-8.
4. Rawlings DJ, Saffran DC, Tsukada S et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient xid mice. Science 1993;261:358-61.
5. Khan W, Gerstein R, Malynn B et al. Defective B cell development and function in Btk deficient mice. Immunity 1995;3:283-99.
6. Kerner JD, Appleby MW, Mohr RN et al. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 1995;3:301-12.
7. Wicker LS, Scher I. X-linked immune deficiency (xid) of CBA/N mice. Curr Top Microbiol Immunol 1986;124:87-101.
8. Sideras P, Smith CIE. Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol 1995;59:135-223.
9. Baixeras E, Kroemer G, Cuende E et al. Signal transduction pathways involved in B-cell induction. Immunol Rev 1993;132:5-47.
10. Sherr CJ, Roberts JM. Inhibitors of mammalian Gl cyclin-dependent kinases. Genes Dev 1995;9:1149-63.
11. Kipl. a cyclin-dependent kinase inhibitor and a potential mediator of extra-cellular antimitogenic signals. Cell 1994;78:59-66.
12. Solvason N, Wu WW, Kabra N, Wu X, Lees E, Howard MC. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J Exp Med 1996;184:407-17.
13. Brorson K, Brunswick M, Ezhevsky S et al. xid affects events leading to B cell cycle entry. J Immunol 1997;159:135-43.
14. L permits anti-Immunoglobulin (Ig)-induced proliferation in xid B cells. J Exp Med 1998;187:1081-90.
15. Rabinovitch PS, Kubbies M, Chen YC, Schindler D, Hoehn H. BrdU-Hoechst flow cytometry: a unique tool for quantitative cell cycle analysis. Exp Cell Res 1988;174:309-18.
16. Sieckmann DG, Scher I, Asofsky R, Mosier DE, Paul WE. Activation of mouse lymphocytes by anti-immunoglobulin. II. A thymus-independent response by a mature subset of B lymphocytes. J Exp Med 1978;148:1628-43.
17. Rothstein TL, Baeker TR, Miller RA, Kolber DL. Stimulation of murine B cells by the combination of calcium ionophore plus phorbol ester. Cell Immunol 1986;102:364-73.
18. Klaus GG, O'Garra A, Bijsterbosch MK, Holman M. Activation and proliferation signals in mouse B cells. VIII. Induction of DNA synthesis in B cells by a combination of calcium ionophores and phorbol myristale acetate. Eur J Immunol 1986;16:92-7.
19. Ahmed S, Lee J, Kozma R, Best A, Monfries C, Lim L. A novel functional target for tumor-promoting phorbol esters and lysophosphatidic acid. The p21rac-GTPase activating protein n-chimaerin. J Biol Chem 1993;268:10709-12.
20. Kazanietz MG, Lewin NE, Bruns JD, Blumberg PM, Characterization of the cysteine-rich region of the Caenorhabditis elegans protein Unc-13 as a high affinity phorbol ester receptor. Analysis of ligand-binding interactions, lipid cofactor requirements, and inhibitor sensitivity. J Biol Chem 1995;270:10777-83.
21. Lindsberg ML, Brunswick M, Yamada H et al. Biochemical analysis of the immune B cell defect in xid mice. J Immunol 1991;147:3774-9.
22. Oka Y, Rolink AG, Andersson J et al. Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes. Int Immunol 1996;8:1675-85.
23. Woodland RT, Schmidt MR, Korsmeyer SJ, Gravel KA. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2. J Immunol 1996;156:2143-54.
24. Anderson JS, Teutsch M, Dong Z, Wortis HH. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis. Proc Natl Acad Sci USA 1996;93:10966-71.
25. Khan WN, Nilsson A, Mizoguchi E et al. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40. Int Immunol 1997;9:395-405.
26. 1 checkpoint. Mol Cell Biol 1996;16:6917-25.
27. Weinberg R. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30.
28. Satterthwaite AB, Cheroutre H, Khan WN, Sideras P, Witte ON. Btk dosage determines sensitivity to B cell antigen receptor cross-linking. Proc Natl Aacd Sci USA 1997;94:13152-7.
29. Maas A, Dingjan GM, Savelkoul HF, Kinnon C, Grosveld F, Hendriks RW. The X-linked immunodeficiency defect in the mouse is corrected by expression of human Bruton's tyrosine kinase from a yeast artificial chromosome transgene. Eur J Immunol 1997;27:2180-7.
30. Hendriks RW, de Bruijn MF, Maas A, Dingjan GM, Karis A, Grosveld F. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. EMBO J 1996;15:4862-72.
31. Carman JA, Wechsler-Reya RJ, Monroe JG. Immature stage B cells enter but do not progress beyond the early Gl phase of the cell cycle in response to antigen receptor signaling. J Immunol 1996;156:4562-9.
32. Klaus GG, Holman M, Johnson Leger C, Elgueta-Karstegl C, Atkins C. A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse. Eur J Immunol 1997;27:2749-56.
33. Lam KP, Kuhn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997;90:1073-83.
34. Reth M, Weinands J. Initiation and processing of signals from the B cell antigen receptor. Annu Rev Immunol 1997;15:453-79.
35. Jaken S. Protein kinase C isozymes and substrates. Curt Opin Cell Biol 1996;8:168-73.
36. Harnett MM, Holman MJ, Klaus GGB. IL-4 promotes anti-Ig-mediated protein kinase C translocation and reverses phorbol ester-mediated protein kinase C downregulation in murine B cells. J Immunol 1991;147:3831-6.
37. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484-96.
38. Rigley KP, Harnett MM, Philips RJ, Klaus GGB. Analysis of signaling via surface immunoglobulin receptors on B cells from CBA/N mice. Eur J Immunol 1989;19:2081-6.
39. Leitges M, Schmedt C, Guinamard R et al. Immunodeficiency in Protein kinase Cβ-deficient mice. Science 1996;273:788-91.